第一季度生物健康制造业销售额增长7.9%，增长势头放缓

Core Insights - The biopharmaceutical industry in South Korea experienced a year-on-year sales growth of 7.9% in the first quarter, although this represents a slowdown of 3.4 percentage points compared to the previous quarter [1] Industry Performance - The medical device sector saw an increase in growth rate from 1.2% to 2.8% - The pharmaceutical sector's growth rate decreased from 14.0% to 8.8% - The cosmetics sector's growth rate fell from 10.7% to 8.7% - Overall, the growth rate of the biopharmaceutical industry remains higher than the average manufacturing growth rate of 2.8% [1][1] Profitability Metrics - The operating profit margin for the biopharmaceutical industry was 10.7%, an increase of 1.9% year-on-year - The pharmaceutical industry's profit margin improved from 7.3% to 10.8% - The cosmetics industry's profit margin rose from 9.4% to 11.2% - The medical device sector's profit margin decreased from 13.6% to 9.4% [1][1][1] Financial Health - The pre-tax net profit margin increased from 11.3% to 12.3%, indicating a recovery in profitability levels - The debt ratio and reliance on borrowing for this manufacturing sector are significantly better than the overall manufacturing industry, reflecting a robust financial structure [1][1]